纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2023-12-31 | BMRN | 拜玛林制药 | 买入 | 1443.36 | 19.16% |
| 2023-12-31 | SGEN | Seagen Inc | 买入 | 1380.56 | 18.32% |
| 2023-12-31 | ARGX | argenx SE ADR | 买入 | 1153.43 | 15.31% |
| 2023-12-31 | INCY | 因塞特医疗 | 买入 | 1120.35 | 14.87% |
| 2023-12-31 | SNY | 赛诺菲 | 买入 | 1119.54 | 14.86% |
| 2023-12-31 | RPRX | Royalty Pharma plc-A | 买入 | 1035.29 | 13.74% |
| 2023-12-31 | VTRS | Viatris Inc | 买入 | 999.79 | 13.27% |
| 2023-12-31 | NBIX | 神经分泌生物科学 | 买入 | 950.88 | 12.62% |
| 2023-12-31 | UTHR | 联合治疗 | 买入 | 898.51 | 11.93% |
| 2023-12-31 | BNTX | BioNTech SE ADR | 买入 | 841.61 | 11.17% |
| 2023-12-31 | SRPT | Sarepta Therapeutics Inc | 买入 | 746.68 | 9.91% |
| 2023-12-31 | MEDP | Medpace Holdings Inc | 买入 | 715.73 | 9.5% |
| 2023-12-31 | KRTX | Karuna Therapeutics Inc | 买入 | 700.16 | 9.29% |
| 2023-12-31 | ROIV | Roivant Sciences Ltd | 买入 | 690.12 | 9.16% |
| 2023-12-31 | BGNE | 百济神州 | 买入 | 652.07 | 8.65% |
| 2023-12-31 | JAZZ | 爵士制药 | 买入 | 648.35 | 8.61% |
| 2023-12-31 | EXEL | 伊克力西斯 | 买入 | 565 | 7.5% |
| 2023-12-31 | IONS | Ionis Pharmaceuticals Inc | 买入 | 562.18 | 7.46% |
| 2023-12-31 | APLS | Apellis Pharmaceuticals Inc | 买入 | 541.33 | 7.19% |
| 2023-12-31 | IMGN | ImmunoGen Inc | 买入 | 530.9 | 7.05% |
公告&资料
